Deepa Khare
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Deepa Khare has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Youngsook Lee
Pohang University of Science and Technology
5 shared publications Enrico Martinoia
Division of Integrative Bioscience and Biotechnology, POSTECH, Pohang, Republic of Korea
4 shared publicationsRishabh Rajkumar Jadhav
Department of Biotechnology, School of Engineering and Applied Sciences, Bennett University, Greater Noida, India
4 shared publicationsSimran Jatwani
Department of Biotechnology, School of Engineering and Applied Sciences, Bennett University, Greater Noida, India
4 shared publicationsFalguni Aggarwal
Department of Biotechnology, School of Engineering and Applied Sciences, Bennett University, Greater Noida, India
3 shared publicationsJae-Ung Hwang
Division of Integrative Bioscience and Biotechnology, POSTECH, Pohang, Republic of Korea
2 shared publications
Latest Publications
- 9 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 333 (Pt 2) , 148932
Functional production of recombinant lysostaphin in Nicotiana benthamiana: A sustainable antimicrobial strategy against drug-resistant Staphylococcus aureus
- 9 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 333 (Pt 2) , 148932
Functional production of recombinant lysostaphin in Nicotiana benthamiana: A sustainable antimicrobial strategy against drug-resistant Staphylococcus aureus
- 29 October 2025
- Published by Springer Nature in Molecular Biotechnology
- Vol. 68 (5) , 2549-2559
Engineered CRISPR-Cas9 Vector for Efficient Agrobacterium-Mediated Transformation of Phanerochaete chrysosporium
Phanerochaete chrysosporium is a model white-rot-fungus with exceptional lignolytic activity, but its genetic manipulation has remained a major challenge due to low transformation efficiencies. Here, we report the development of an optimized Agrobacterium-mediated transformation (AMT) protocol optimized for this species. A CRISPR-Cas9 compatible binary vector was modified by replacing the mCherry cassette with a strong sGFP reporter under the constitutive 35S promoter, enabling reliable identification of transformants. Using mycelial disks as starting material and applying a sandwich selection method, we achieved stable integration of T-DNA carrying the hygromycin resistance and sGFP genes. Transformation efficiency was influenced by co-cultivation parameters, with low-temperature incubation (23°C) and the addition of acetosyringone significantly improving recovery of resistant colonies. Stable expression of sGFP was observed in transformed mycelia, confirming the reproducibility of the system. Although CRISPR-Cas9-mediated gene editing was not demonstrated in this study, our results provide proof-of-concept that a Cas9-based vector can be stably maintained in P. chrysosporium and drive heterologous gene expression. This work represents the first step toward establishing a functional genome editing platform in this ligninolytic fungus. By expanding the molecular toolbox for P. chrysosporium, the optimized transformation strategy lays the foundation for metabolic engineering aimed at lignin valorization, bioplastics, biofuels, and high-value biochemical production within a sustainable circular bioeconomy framework.
- 29 October 2025
- Published by Springer Nature in Molecular Biotechnology
- Vol. 68 (5) , 2549-2559
Engineered CRISPR-Cas9 Vector for Efficient Agrobacterium-Mediated Transformation of Phanerochaete chrysosporium
Phanerochaete chrysosporium is a model white-rot-fungus with exceptional lignolytic activity, but its genetic manipulation has remained a major challenge due to low transformation efficiencies. Here, we report the development of an optimized Agrobacterium-mediated transformation (AMT) protocol optimized for this species. A CRISPR-Cas9 compatible binary vector was modified by replacing the mCherry cassette with a strong sGFP reporter under the constitutive 35S promoter, enabling reliable identification of transformants. Using mycelial disks as starting material and applying a sandwich selection method, we achieved stable integration of T-DNA carrying the hygromycin resistance and sGFP genes. Transformation efficiency was influenced by co-cultivation parameters, with low-temperature incubation (23°C) and the addition of acetosyringone significantly improving recovery of resistant colonies. Stable expression of sGFP was observed in transformed mycelia, confirming the reproducibility of the system. Although CRISPR-Cas9-mediated gene editing was not demonstrated in this study, our results provide proof-of-concept that a Cas9-based vector can be stably maintained in P. chrysosporium and drive heterologous gene expression. This work represents the first step toward establishing a functional genome editing platform in this ligninolytic fungus. By expanding the molecular toolbox for P. chrysosporium, the optimized transformation strategy lays the foundation for metabolic engineering aimed at lignin valorization, bioplastics, biofuels, and high-value biochemical production within a sustainable circular bioeconomy framework.
- 30 May 2025
- Published by IGI Global Scientific Publishing
- p. 325-380
Nature's Cure
Secondary metabolites are organic compounds produced by microorganisms, higher plants, and fungi, with significant ecological and human health relevance. This chapter explores their biological activities, types, and biosynthesis, emphasizing their applications in disease prevention and control. It highlights the pharmacological properties of key compounds, including phenolics, alkaloids, flavonoids, terpenoids, glycosides, and polyketides, in treating and preventing cancer, diabetes, heart diseases, infections, mental disorders, and immune system dysfunctions. Their roles in combating aging, inflammation, oxidative stress, neurodegeneration, malaria, and modulating immunity are also discussed.
- 30 May 2025
- Published by IGI Global Scientific Publishing
- p. 325-380
Nature's Cure
Secondary metabolites are organic compounds produced by microorganisms, higher plants, and fungi, with significant ecological and human health relevance. This chapter explores their biological activities, types, and biosynthesis, emphasizing their applications in disease prevention and control. It highlights the pharmacological properties of key compounds, including phenolics, alkaloids, flavonoids, terpenoids, glycosides, and polyketides, in treating and preventing cancer, diabetes, heart diseases, infections, mental disorders, and immune system dysfunctions. Their roles in combating aging, inflammation, oxidative stress, neurodegeneration, malaria, and modulating immunity are also discussed.
- 3 March 2025
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 30 (3) , 423-445
Enhancing camptothecin yields: innovative approaches for sustainable anticancer drug production
- 3 March 2025
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 30 (3) , 423-445
Enhancing camptothecin yields: innovative approaches for sustainable anticancer drug production
- 21 June 2024
- Published by Springer Nature in Plant Biotechnology Reports
- Vol. 18 (4) , 465-486
Green biotherapeutics: overcoming challenges in plant-based expression platforms
- 21 June 2024
- Published by Springer Nature in Plant Biotechnology Reports
- Vol. 18 (4) , 465-486
Green biotherapeutics: overcoming challenges in plant-based expression platforms
- 26 May 2022
- Published by Elsevier in Letters in Drug Design & Discovery
- Vol. 20 (5) , 570-580
Virtual Screening of Novel Phytocompound(s) with Potential to Combat Mycobacterium tuberculosis Infection
Background: Tuberculosis is a worldwide health concern, and there is an immediate need for effective therapeutics to inhibit the infection caused by Mycobacterium tuberculosis. The persistent state of bacteria and the emergence of Multi-Drug Resistance are the two major reasons for the difficulty in treating tuberculosis. Objective: The study aims to identify novel phytocompounds to effectively inhibit Mycobacterium tuberculosis by targeting the Esx-1 protein, which plays a vital function in the secretion pathway of M. tuberculosis to successfully disrupt the host cell and cause tuberculosis. Method: In the current study, ~500 novel phytocompounds were screened by docking against Esx-1 using AutoDock Vina 4.2 version. The visualization analysis for selected phytocompounds was performed using Protein-Ligand Interaction Profiler. A comparative study with a well-known drug for tuberculosis, Rifampicin, was also performed. Moreover, ADMET analysis was performed to check the druggability and pharmacokinetic parameters of the selected compounds. Result: Based on the analysis, cadabicine, an alkaloid produced by Cadaba fruticose (Vizhuthi), Crataeva nurvala (Varuna) plants, exhibits the best binding affinity of -7.8 Kcal/mol with the active site residues, Leu 29 and Trp 43, of Esx-1, which are required for the stability of Esx-1 and virulence of M. tuberculosis in the host cell. ADMET analysis showed that cadabicine exhibits better druggability and pharmacokinetic parameters than other selected compounds. Conclusion: Cadabicine possesses an acceptable binding affinity with the active site of Esx-1 and exhibits acceptable physicochemical and pharmacokinetic properties, which makes it a potential new drug candidate for the treatment of tuberculosis.
- 26 May 2022
- Published by Elsevier in Letters in Drug Design & Discovery
- Vol. 20 (5) , 570-580
Virtual Screening of Novel Phytocompound(s) with Potential to Combat Mycobacterium tuberculosis Infection
Background: Tuberculosis is a worldwide health concern, and there is an immediate need for effective therapeutics to inhibit the infection caused by Mycobacterium tuberculosis. The persistent state of bacteria and the emergence of Multi-Drug Resistance are the two major reasons for the difficulty in treating tuberculosis. Objective: The study aims to identify novel phytocompounds to effectively inhibit Mycobacterium tuberculosis by targeting the Esx-1 protein, which plays a vital function in the secretion pathway of M. tuberculosis to successfully disrupt the host cell and cause tuberculosis. Method: In the current study, ~500 novel phytocompounds were screened by docking against Esx-1 using AutoDock Vina 4.2 version. The visualization analysis for selected phytocompounds was performed using Protein-Ligand Interaction Profiler. A comparative study with a well-known drug for tuberculosis, Rifampicin, was also performed. Moreover, ADMET analysis was performed to check the druggability and pharmacokinetic parameters of the selected compounds. Result: Based on the analysis, cadabicine, an alkaloid produced by Cadaba fruticose (Vizhuthi), Crataeva nurvala (Varuna) plants, exhibits the best binding affinity of -7.8 Kcal/mol with the active site residues, Leu 29 and Trp 43, of Esx-1, which are required for the stability of Esx-1 and virulence of M. tuberculosis in the host cell. ADMET analysis showed that cadabicine exhibits better druggability and pharmacokinetic parameters than other selected compounds. Conclusion: Cadabicine possesses an acceptable binding affinity with the active site of Esx-1 and exhibits acceptable physicochemical and pharmacokinetic properties, which makes it a potential new drug candidate for the treatment of tuberculosis.
- 3 February 2020
- Published by Springer Nature in Plant Cell Reports
- Vol. 39 (4) , 473-487
Non-intrinsic ATP-binding cassette proteins ABCI19, ABCI20 and ABCI21 modulate cytokinin response at the endoplasmic reticulum in Arabidopsis thaliana
The non-intrinsic ABC proteins ABCI20 and ABCI21 are induced by light under HY5 regulation, localize to the ER, and ameliorate cytokinin-driven growth inhi
- 3 February 2020
- Published by Springer Nature in Plant Cell Reports
- Vol. 39 (4) , 473-487
Non-intrinsic ATP-binding cassette proteins ABCI19, ABCI20 and ABCI21 modulate cytokinin response at the endoplasmic reticulum in Arabidopsis thaliana
The non-intrinsic ABC proteins ABCI20 and ABCI21 are induced by light under HY5 regulation, localize to the ER, and ameliorate cytokinin-driven growth inhi
- 26 June 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (28) , E5712-E5720
Arabidopsis ABCG34 contributes to defense against necrotrophic pathogens by mediating the secretion of camalexin
Significance: Alternaria brassicicola infection causes dark spots on the leaves of most Brassica species, reducing the yield of economically important oilseed crops. In response to A . brassicicola infection, Arabidopsis thaliana and other Brassicaceae produce and secrete camalexin, a major phytoalexin imparting resistance to A . brassicicola . Because camalexin is toxic to the plant itself, specific transporters are needed for secretion. Here we show that the ABC transporter ABCG34 mediates the secretion of camalexin from the epidermal cells to the surface of leaves and thereby confers resistance to A . brassicicola infection. This work establishes a complete picture of a plant defense system, consisting of a toxic secondary metabolite, its transporter, and the disease phenotype caused by an economically important pathogen.
- 26 June 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (28) , E5712-E5720
Arabidopsis ABCG34 contributes to defense against necrotrophic pathogens by mediating the secretion of camalexin
Significance: Alternaria brassicicola infection causes dark spots on the leaves of most Brassica species, reducing the yield of economically important oilseed crops. In response to A . brassicicola infection, Arabidopsis thaliana and other Brassicaceae produce and secrete camalexin, a major phytoalexin imparting resistance to A . brassicicola . Because camalexin is toxic to the plant itself, specific transporters are needed for secretion. Here we show that the ABC transporter ABCG34 mediates the secretion of camalexin from the epidermal cells to the surface of leaves and thereby confers resistance to A . brassicicola infection. This work establishes a complete picture of a plant defense system, consisting of a toxic secondary metabolite, its transporter, and the disease phenotype caused by an economically important pathogen.